ArticleThe Journal of biological chemistry2019

Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice.

Kai Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.